Related Experiment Videos
Increased CD5-positive B lymphocytes in type I diabetes
1Endocrinology and Diabetes Unit, Hospital Clinic, University of Barcelona, Spain.
Clinical and Experimental Immunology
|February 1, 1991
Summary
Increased CD5+ B lymphocytes were found in 39.2% of type I diabetes patients, suggesting a potential role for these cells in autoimmune disease pathogenesis. These cells remained a stable phenotype over time.
Area of Science:
- Immunology
- Endocrinology
- Autoimmune Diseases
Background:
- CD5+ B lymphocytes produce antibodies targeting self-antigens.
- Elevated CD5+ B cell proportions are observed in autoimmune conditions.
- The role of CD5+ B cells in type I diabetes (T1D) is not fully understood.
Purpose of the Study:
- To investigate the proportion of peripheral blood CD5+ B lymphocytes in type I diabetic patients.
- To explore the relationship between CD5+ B cells, autoantibodies, and disease duration in T1D.
Main Methods:
- Flow cytometry analysis of peripheral blood lymphocytes.
- Comparison of CD5+ B cell proportions between T1D patients and healthy controls.
- Longitudinal follow-up of CD5+ B cell phenotype in a subset of patients.
Main Results:
- 39.2% of type I diabetic patients exhibited increased circulating CD5+ B lymphocytes compared to healthy controls.
- No significant correlation was found between increased CD5+ B cells and serum islet cell or insulin autoantibodies.
- Increased CD5+ B lymphocyte proportions were independent of diabetes duration.
- CD5+ B cell proportion remained a stable phenotype over a 1-year follow-up.
Conclusions:
- A subset of type I diabetic patients shows elevated CD5+ B lymphocytes.
- CD5+ B cells may play a role in the pathogenesis of type I diabetes.
- Further research is needed to establish the clinical significance of these findings.